1. Device-device communication stability of leadless anti-tachycardia pacemaker and subcutaneous implantable cardioverter defibrillator over 18 months. (25th November 2020) Authors: Tjong, F.V.Y; Knops, R.E; Swackhamer, B; Koop, B; Soltis, B; Brisben, A; Carter, N; Burke, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The incidence and clinical ramifications for leadless pacemaker fixation mechanism exposure on the epicardial surface. (24th May 2021) Authors: Breeman, KTN; Burke, MC; Shuros, A; Soltis, B; Brisben, A; Kilvington, J; Swackhamer, B; Knops, RE; Tjong, FVY Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tricuspid and mitral valve regurgitation in a chronic canine model implanted with a novel leadless pacemaker. (24th May 2021) Authors: Breeman, KTN; Knops, RE; Swackhamer, B; Kilvington, J; Soltis, B; Shuros, A; Brisben, A; Carter, N; Burke, MC; Tjong, FVY Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗